References
- Giardine B, Borg J, Viennas E, et al. Update of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucleic Acid Res. 2014;42(Database issue):D1063–D1069 (http://globin.cse.psu.edu).
- Divoky V, Baysal E, Oner R, et al. The T→C mutation at position +96 of the untranslated region 3′ to the terminating codon of the β-globin gene is a rare polymorphism that does not cause a β-thalassemia as previously ascribed. Hum Genet. 1994;93(1):77–78.
- Boussiou M, Karababa P, Sinopoulou K, et al. The molecular heterogeneity of β thalassemia in Greece. Blood Cells Mol Dis. 2008;40(3):317–319.
- Bilgen T, Canatan D, Arican Y, et al. The effect of HBB: c*+96 T>C (3′UTR +1570T>C) on mild β-thalassemia intermedia phenotype. Turk J Hematol. 2011;28(3):219–222.
- Vinciguerra M, Passarello C, Cassara F, et al. Co-heredity of silent CAP +1570 T>C (HBB:c*96T>C) defect and severe β-thal mutation: a cause of mild β-thalassemia intermedia. Int J Lab Hematol. 2016;38(1):17–26.
- Taher AT, Porter JB, Viprakasit V, et al. Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study. Ann Hematol. 2013;92(11):1485–1493.